Feed Items
- previous post: Carbapenems vs alternative β-lactams for the treatment of nosocomial pneumonia: A systematic review and meta-analysis
- next post: OPTIMAL and ENSURE trials-based combined cost-effectiveness analysis of erlotinib vs chemotherapy for the first-line treatment of Asian patients with non-squamous non-small-cell lung cancer
